Ferdinando Clarelli

5PUBLICATIONS
16CO-AUTHORS
Nanotoxicology, health and safetyGene and molecular therapyNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2026
Anti-CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis.

|Mar 03, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Andrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen

|Nov 27, 2025
Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional Implications.

Kaalindi Misra, Aishwary Nerkar, Ferdinando Clarelli

|Jun 30, 2025
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis.

Ferdinando Clarelli, Melissa Sorosina, Antonino Giordano

|Mar 13, 2025
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis.

Antonino Giordano, Arianna Giliberti, Ferdinando Clarelli

Pageof 1

Frequent Collaborators

4 joint publications

Antonino Giordano

4 joint publications

Maria Assunta Rocca

4 joint publications

Massimo Filippi

2 joint publications

Melissa Sorosina